Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ronran, let me ask you a very straight forward question,

Not in any way hoping for fluff or boilerplate releases, but it is customary for companies to release a PR commenting on quarterly/yearly earnings. This would NOT, in my opinion, be the sort of thing that would prompt "massive dumping" by large shareholders, unless, of course, the release contained previously hitherto unknown information that would prompt such large shareholders to do so.

This is customary. This is professional. This is expected. For ANY publicly traded company.

So -- Hawk/Hoffman -- you have 15 minutes to deliver. And when you do, please make sure Dutton has CORRECT figures. Thank you very much.

JMHO.

Share
New Message
Please login to post a reply